Alexander P Boardman - JoVE Visualize

Showing results (1-10 of 18) with videos related to

Pageof 2

Sort By:

Hematological Oncology|June 9, 2023

CAR T-cell therapy in large B cell lymphomaAlexander P Boardman, Gilles Salles

Journal of Visualized Experiments : Jove|November 10, 2025

Leucine Zipper-based Cell Sorting for Purification of Dual-vector-transduced CellsKaterina Su, Bintao Wang, Adhithi Rajagopalan, et al.

Advances in Therapy|May 15, 2026

Indirect Treatment Comparisons of Lisocabtagene Maraleucel Versus Axicabtagene Ciloleucel and Tisagenlecleucel in Third-Line or Later Relapsed or Refractory Follicular LymphomaAlexander P Boardman, Juan Luis Reguera Ortega, Pearl Wang, et al.

Molecular Cell|June 9, 2015

Quantitative Proteomic Atlas of Ubiquitination and Acetylation in the DNA Damage ResponseAndrew E H Elia, Alexander P Boardman, David C Wang, et al.

Molecular Cell|October 17, 2015

RFWD3-Dependent Ubiquitination of RPA Regulates Repair at Stalled Replication ForksAndrew E H Elia, David C Wang, Nicholas A Willis, et al.

Blood|April 5, 2024

IL-18-secreting multiantigen targeting CAR T cells eliminate antigen-low myeloma in an immunocompetent mouse modelBrandon D Ng, Adhithi Rajagopalan, Anastasia I Kousa, et al.

Bone Marrow Transplantation|November 18, 2025

Late hematologic toxicity after CAR T-cell therapy in large B-cell lymphoma: incidence, risk factors, and clinical impactMagdalena Corona, Samantha Brown, Kai Rejeski, et al.

Clinical Lymphoma, Myeloma & Leukemia|March 25, 2026

Epcoritamab Monotherapy as Outpatient Treatment for Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Interim Results From EPCORE NHL-6David Andorsky, Adelba Torres Lopez, Rakhee Vaidya, et al.

Haematologica|November 21, 2024

Predictors and implications of renal injury after CD19 chimeric antigen receptor T-cell therapyAlexander P Boardman, Victoria Gutgarts, Jessica Flynn, et al.

Hemasphere|December 1, 2025

Patterns and safety of glucocorticosteroid use following CD19 CAR-T therapy for large B-cell lymphomaEfrat Luttwak, David Nemirovsky, Sean M Devlin, et al.

Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:

Pageof 2

Hematological Oncology|June 9, 2023

CAR T-cell therapy in large B cell lymphomaAlexander P Boardman, Gilles Salles

Journal of Visualized Experiments : Jove|November 10, 2025

Leucine Zipper-based Cell Sorting for Purification of Dual-vector-transduced CellsKaterina Su, Bintao Wang, Adhithi Rajagopalan, et al.

Advances in Therapy|May 15, 2026

Indirect Treatment Comparisons of Lisocabtagene Maraleucel Versus Axicabtagene Ciloleucel and Tisagenlecleucel in Third-Line or Later Relapsed or Refractory Follicular LymphomaAlexander P Boardman, Juan Luis Reguera Ortega, Pearl Wang, et al.

Molecular Cell|June 9, 2015

Quantitative Proteomic Atlas of Ubiquitination and Acetylation in the DNA Damage ResponseAndrew E H Elia, Alexander P Boardman, David C Wang, et al.

Molecular Cell|October 17, 2015

RFWD3-Dependent Ubiquitination of RPA Regulates Repair at Stalled Replication ForksAndrew E H Elia, David C Wang, Nicholas A Willis, et al.

Blood|April 5, 2024

IL-18-secreting multiantigen targeting CAR T cells eliminate antigen-low myeloma in an immunocompetent mouse modelBrandon D Ng, Adhithi Rajagopalan, Anastasia I Kousa, et al.

Bone Marrow Transplantation|November 18, 2025

Late hematologic toxicity after CAR T-cell therapy in large B-cell lymphoma: incidence, risk factors, and clinical impactMagdalena Corona, Samantha Brown, Kai Rejeski, et al.

Clinical Lymphoma, Myeloma & Leukemia|March 25, 2026

Epcoritamab Monotherapy as Outpatient Treatment for Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Interim Results From EPCORE NHL-6David Andorsky, Adelba Torres Lopez, Rakhee Vaidya, et al.

Haematologica|November 21, 2024

Predictors and implications of renal injury after CD19 chimeric antigen receptor T-cell therapyAlexander P Boardman, Victoria Gutgarts, Jessica Flynn, et al.

Hemasphere|December 1, 2025

Patterns and safety of glucocorticosteroid use following CD19 CAR-T therapy for large B-cell lymphomaEfrat Luttwak, David Nemirovsky, Sean M Devlin, et al.

Pageof 2